Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 6821 from our risk checks.
Asymchem Laboratories (Tianjin) Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥50.35 |
52 Week High | CN¥123.30 |
52 Week Low | CN¥50.15 |
Beta | 0.10 |
11 Month Change | -9.28% |
3 Month Change | -20.90% |
1 Year Change | -43.27% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -76.07% |
Recent News & Updates
Recent updates
Shareholder Returns
6821 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -3.2% | -4.1% | 0.6% |
1Y | -43.3% | -3.5% | 2.4% |
Return vs Industry: 6821 underperformed the Hong Kong Pharmaceuticals industry which returned -3.5% over the past year.
Return vs Market: 6821 underperformed the Hong Kong Market which returned 2.4% over the past year.
Price Volatility
6821 volatility | |
---|---|
6821 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 5.5% |
Market Average Movement | 7.2% |
10% most volatile stocks in HK Market | 15.1% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 6821's share price has been volatile over the past 3 months.
Volatility Over Time: 6821's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 9,788 | Hao Hong | www.asymchem.com.cn |
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services.
Asymchem Laboratories (Tianjin) Co., Ltd. Fundamentals Summary
6821 fundamental statistics | |
---|---|
Market cap | HK$26.23b |
Earnings (TTM) | HK$2.06b |
Revenue (TTM) | HK$7.50b |
13.1x
P/E Ratio3.6x
P/S RatioIs 6821 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6821 income statement (TTM) | |
---|---|
Revenue | CN¥6.98b |
Cost of Revenue | CN¥3.46b |
Gross Profit | CN¥3.51b |
Other Expenses | CN¥1.59b |
Earnings | CN¥1.92b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.46 |
Gross Margin | 50.36% |
Net Profit Margin | 27.53% |
Debt/Equity Ratio | 0.07% |
How did 6821 perform over the long term?
See historical performance and comparison